Chemoinformaics analysis of 1-O-vanilloyl-beta-D-glucose
Molecular Weight | 330.289 | nRot | 4 |
Heavy Atom Molecular Weight | 312.145 | nRig | 13 |
Exact Molecular Weight | 330.095 | nRing | 2 |
Solubility: LogS | -1.443 | nHRing | 1 |
Solubility: LogP | -0.642 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
nHA | 9 | APOL | 42.6003 |
nHD | 5 | BPOL | 24.1337 |
QED | 0.41 |
Synth | 3.425 |
Natural Product Likeliness | 1.813 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.214 |
HIA | 0.903 |
CACO-2 | -5.959 |
MDCK | 0.000248735 |
BBB | 0.806 |
PPB | 0.32957 |
VDSS | 0.45 |
FU | 0.541515 |
CYP1A2-inh | 0.04 |
CYP1A2-sub | 0.07 |
CYP2c19-inh | 0.011 |
CYP2c19-sub | 0.109 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.477 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.224 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.02 |
CL | 4.886 |
T12 | 0.84 |
hERG | 0.019 |
Ames | 0.211 |
ROA | 0.014 |
SkinSen | 0.025 |
Carcinogencity | 0.043 |
EI | 0.014 |
Respiratory | 0.018 |
NR-Aromatase | 0.018 |
Antiviral | Yes |
Prediction | 0.591589 |